About Toxic Reports
Toxic Reports offers analytical services for rapid testing of persistent organic pollutants (POPs) in food and the environment. The company's franchise laboratories are ISO 17025 accredited providing high quality analytical testing of Persistent organic pollutants (POPs). Unlike other analytical labs which offer analytical services for everything, Toxic Reports focus is POPs. Toxic Reports uses the power of advanced analytical instrumentation combined with automated sample preparation create the world's fastest, lowest cost, highest quality expertise in high resolution (HR/MS) Testing.
Want to inform investors similar to Toxic Reports about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Toxic Reports News
Oct 1, 2015
Verify here. The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com. All rights reserved. All other trademarks recognized. Copyright © 1997-2015 BioPortfolio Limited. Site developed by Alacrify Ltd .
Toxic Reports Acquisitions
1 Acquisition
Toxic Reports acquired 1 company. Their latest acquisition was PathoGenetix on February 13, 2015.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
2/13/2015 | Series C | $117.71M | Asset Sale | 1 |
Date | 2/13/2015 |
|---|---|
Investment Stage | Series C |
Companies | |
Valuation | |
Total Funding | $117.71M |
Note | Asset Sale |
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.